Esophageal Carcinoma — Trials

Esophageal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 307
Recruiting: 179
Ph III recruiting: 26
Growth YoY: +33.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (62)

clinicaltrialsPublishedShowing 51–100 of 430 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07403136	Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC	recruiting	Phase 2	104	Fudan UniversityOTHER	1	Jul 7, 2026	clinicaltrials
NCT07688291	A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy	not yet recruiting	Phase 2	40	Beijing GoBroad HospitalOTHER	1	Jul 7, 2026	clinicaltrials